Minimal Residual Disease Monitoring from Liquid Biopsy By Next Generation Sequencing in Follicular Lymphoma Patients

被引：2
|
作者：
Ubieto, Ana Isabel Jiminez
Heredia, Yanira
de la Rosa, Juan Manuel
Izquierdo, Antonia Rodriguez
Rufian, Laura
Carrillo, Jaime
Sanchez, Ricardo
Onecha, Esther
Wang, Chongwu
Sarandeses, Pilar
Poza, Maria
Barcena, Carmen
Grande, Carlos
Canales, Miguel A.
Rapado, Inmaculada
Ayala, Rosa
Gallardo, Miguel
Martinez-Lopez, Joaquin
Barrio, Santiago
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-139256
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Targeted Locus Amplification (TLA): A Novel Next Generation Sequencing (NGS) Technology to Detect New Molecular Markers and Monitoring Minimal Residual Disease (MRD) in Mantle Cell and Follicular Lymphoma
    Genuardi, Elisa
    Klous, Petra
    Drandi, Daniela
    Mantoan, Barbara
    Monitillo, Luigia
    Daniela, Barbero
    Yilmaz, Mehmet
    Cattellino, Fabio
    Vasta, Marika
    Furia, Federica
    Zaccaria, Gian Maria
    Cavallo, Federica
    Cortelazzo, Sergio
    Vitolo, Umberto
    Luminari, Stefano
    Federico, Massimo
    Boccadoro, Mario
    Splinter, Erik
    Ladetto, Marco
    Ferrero, Simone
    BLOOD, 2017, 130
  • [22] Next-generation sequencing-based liquid biopsy may be used for detection of residual disease and cancer recurrence monitoring in dogs
    McCleary-Wheeler, Angela L.
    Fiaux, Patrick C.
    Flesner, Brian K.
    Ruiz-Perez, Carlos A.
    McLennan, Lisa M.
    Tynan, John A.
    Hicks, Susan C.
    Rafalko, Jill M.
    Grosu, Daniel S.
    Chibuk, Jason
    O'Kell, Allison L.
    Cohen, Todd A.
    Chorny, Ilya
    Tsui, Dana W. Y.
    Kruglyak, Kristina M.
    Flory, Andi
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2024, 85 (03)
  • [23] Monitoring of minimal residual disease after CHOP and Rituximab in previously untreated follicular lymphoma patients.
    Rambaldi, A
    Carlotti, E
    Baccarani, M
    Barbui, T
    Dastoli, G
    Lauria, F
    Lazzarino, M
    Mandelli, F
    Morra, E
    Pulsoni, A
    Rupolo, M
    Tura, S
    Zaja, F
    Zinzani, P
    Reato, G
    Foa, R
    BLOOD, 2001, 98 (11) : 603A - 603A
  • [24] Standardized minimal residual disease detection by next generation sequencing in multiple myeloma
    Yao, Qiumei
    Bai, Yinlei
    Orfao, Alberto
    Chim, James
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E175 - E175
  • [25] Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT
    Jimenez-Ubieto, Ana
    Poza, Maria
    Martin-Munoz, Alejandro
    Ruiz-Heredia, Yanira
    Dorado, Sara
    Figaredo, Gloria
    Rosa-Rosa, Juan Manuel
    Rodriguez, Antonia
    Barcena, Carmen
    Navamuel, Laura Parrilla
    Carrillo, Jaime
    Sanchez, Ricardo
    Rufian, Laura
    Juarez, Alexandra
    Rodriguez, Margarita
    Wang, Chongwu
    de Toledo, Paula
    Grande, Carlos
    Mollejo, Manuela
    Casado, Luis-Felipe
    Calbacho, Maria
    Baumann, Tycho
    Rapado, Inmaculada
    Gallardo, Miguel
    Sarandeses, Pilar
    Ayala, Rosa
    Martinez-Lopez, Joaquin
    Barrio, Santiago
    LEUKEMIA, 2023, 37 (03) : 659 - 669
  • [26] Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC
    Mellert, Hestia
    Reese, Jordan
    Jackson, Leisa
    Maxwell, Victoria
    Tschida, Cherie
    Pestano, Gary A.
    DIAGNOSTICS, 2021, 11 (02)
  • [27] Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT
    Ana Jiménez-Ubieto
    María Poza
    Alejandro Martin-Muñoz
    Yanira Ruiz-Heredia
    Sara Dorado
    Gloria Figaredo
    Juan Manuel Rosa-Rosa
    Antonia Rodriguez
    Carmen Barcena
    Laura Parrilla Navamuel
    Jaime Carrillo
    Ricardo Sanchez
    Laura Rufian
    Alexandra Juárez
    Margarita Rodriguez
    Chongwu Wang
    Paula de Toledo
    Carlos Grande
    Manuela Mollejo
    Luis-Felipe Casado
    María Calbacho
    Tycho Baumann
    Inmaculada Rapado
    Miguel Gallardo
    Pilar Sarandeses
    Rosa Ayala
    Joaquín Martínez-López
    Santiago Barrio
    Leukemia, 2023, 37 : 659 - 669
  • [28] NEXT-GENERATION SEQUENCING AS A TOOL FOR ASSESSING MINIMAL RESIDUAL DISEASE IN AML PATIENTS WITH CEBPA MUTATIONS
    Zejskova, L.
    Plachy, R.
    Sedlackova, L.
    Mazal, O.
    Ondrackova, M.
    Zavrelova, A.
    Zak, P.
    Petecukova, V.
    Novak, J.
    Kozak, T.
    Pekova, S.
    HAEMATOLOGICA, 2015, 100 : 358 - 359
  • [29] Clinical validation of next-generation sequencing as a liquid biopsy for the monitoring of patients with metastatic colorectal cancer
    Zarkavelis, G.
    Kastrisiou, M.
    Papadopoulou, E.
    Nasioulas, G.
    Tselikou, E.
    Mantziou, A.
    Tzallas, C.
    Batistatou, A.
    Magklara, A.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S176 - S176
  • [30] Is There a Role for Minimal Residual Disease Monitoring in Follicular Lymphoma in the Chemo-Immunotherapy Era?
    Gritti, Giuseppe
    Pavoni, Chiara
    Rambaldi, Alessandro
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
12345